Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Psychedelics Financing
Recent news which mentions Psychedelics Financing
Psychedelics Headlines: Substitution Survey, Frank Herbert's Magic Mushrooms, Celestial Plans And News Review
March 16, 2024
Tickers
ATAI
BETRF
CMND
ENVB
Tags
Benzinga
NUMIF
Global
From
Benzinga
MindMed's 2023 Financial Results And Business Recap: Milestones Amid Rising Expenses
February 28, 2024
Tickers
MNMD
Tags
MNMD
Management
Biotech
From
Benzinga
Psychedelics Headlines: Trauma-Informed Care, Valentine's Day & MDMA, Academics On Drugs And More
February 15, 2024
Tickers
ATAI
AWKNF
CMND
CYBN
Tags
Psychedelics Reform
Management
CYBN
From
Benzinga
Seelos Therapeutics' $5.55M Public Offering As Stock Drop 35%
November 29, 2023
Tickers
IPOS
SEEL
Tags
SEEL
News
Public Offering
From
Benzinga
Psyched: Ramaswamy Psychedelics For PTSD, UK Clinical Trials, Johns Hopkins Q&A And More
November 24, 2023
Tickers
ATAI
AWKNF
CMPS
CYBN
Tags
Cannabis
PSIL
Market News
From
Benzinga
Nasdaq On Horizon For Psyence Group: Psilocybin Therapeutics Division Forms New Business Combination
November 16, 2023
Tickers
NCAC
Tags
Contracts
News
M&A
From
Benzinga
Psyched: Veterans & Psychedelics, $100M IPO, Cybin's $64M Offering, Worldwide Events & More
November 12, 2023
Tickers
ATAI
CMPS
CYBN
DRUG
Tags
CMPS
CYBN
Psychedelics Reform
From
Benzinga
Cybin Launches Five-Day Units Offering For Up To $64M, Suspends Prior LPC Funding Deal
November 10, 2023
Tickers
CYBN
Tags
CYBN
Psychedelics
News
From
Benzinga
Psyched: Steve Cohen Goes Big On Cybin, Fed Intervention On Psilocybin, Ketamine Insurance And More
September 26, 2023
Tickers
ATAI
CMPS
CYBN
DMTTF
Tags
Benzinga
Penny Stocks
Psychedelic/Assisted Therapies
From
Benzinga
Psyched: MDMA Trials For PTSD, Congressional Amendments, Scotland's Consumption Site & More
September 18, 2023
Tickers
ATAI
CMND
CMPS
DRUG
Tags
LSDI
ATAI
MNMD
From
Benzinga
Billionaire Steve Cohen Invests $19M In Cybin For Psychedelics R&D, Blake Mycoskie's $100M Pledge Update
September 18, 2023
Tickers
ATAI
CYBN
DMTTF
MNMD
Tags
DMTTF
Markets
CYBN
From
Benzinga
Psychedelics Capital Moves: Beckley Waves Raises $3.3M, Clearmind's $2.25M Public Offering
September 15, 2023
Tickers
CMND
Tags
Penny Stocks
Global
Benzinga
From
Benzinga
Swedish Foundation Supports Mental Health Innovation With New €3M Psychedelic Science Initiative
September 13, 2023
Tickers
CMPS
Tags
Markets
CMPS
News
From
Benzinga
Psyched: Three Noteworthy Psychedelics M&As, Colorado's Regulations, Exclusive Financing & More
September 05, 2023
Tickers
ATAI
BRAXF
CMPS
CYBN
Tags
Benzinga
Global
Psychedelic/Assisted Therapies
From
Benzinga
Psyched: Psilocybin For Gambling Addiction, Ex-NHL Player's Retreat, Fellini's LSD Creativity, Surveys, Financing & More
August 28, 2023
Tickers
ATAI
CMPS
CYBN
DRUG
Tags
ATAI
MNMD
IXHL
From
Benzinga
Psyched: Fed Study On Psychedelics, Janet Yellen's Magic Mushrooms, Financing Deals & Quarterly Reports
August 21, 2023
Tickers
ATAI
CMPS
CYBN
DRUG
Tags
CMPS
CYBN
SEEL
From
Benzinga
Up To $285M In Financing: COMPASS Pathways' Private Placement Backed By 'Select Group' Of Investors
August 16, 2023
Tickers
CMPS
Tags
Management
CMPS
News
From
Benzinga
MindMed Inks $50M Credit Facility Deal With K2 HealthVentures For An Additional Operational Year
August 14, 2023
Tickers
MNMD
Tags
Contracts
Psychedelics
Market News
From
Benzinga
Psyched: Professional Practice Guidelines, DMT For Stroke, Dua Lipa &. Amanda Feilding, Clinical Results & More
August 14, 2023
Tickers
AGNPF
ATAI
AWKNF
CMPS
Tags
GHRS
Events
AWKNF
From
Benzinga
Cybin Closes Short-Lasting Overnight Public Offering With Top Issuance For $8.25M
August 04, 2023
Tickers
CYBN
Tags
News
CYBN
Management
From
Benzinga
Cybin Launches 3-Day Overnight Public Offering For Up To $8.25M, Suspends Prior Purchase Deal
August 01, 2023
Tickers
CYBN
IPOS
Tags
Benzinga
DMT Clinical Trial
Penny Stocks
From
Benzinga
Bright Minds Goes For 5:1 Shares Consolidation, Hopes To Regain NASDAQ Compliance
July 11, 2023
Tickers
DRUG
Tags
Psychedelics
DRUG
Market News
From
Benzinga
Psyched: Australia's Innovative Program, Congressional Amendments, Therapy Reimbursement And More
July 11, 2023
Tickers
AWKNF
CMPS
DMTTF
FLHLF
Tags
Markets
DMTTF
News
From
Benzinga
COMPASS Pathways Secures Up To $50M In Term Loan Facility With Hercules Capital
July 05, 2023
Tickers
ATAI
CMPS
HTGC
Tags
News
CMPS
HTGC
From
Benzinga
Psyched: A $100M Donation Pledge, Frank Biden Gets Candid, New Search Trends & More
July 04, 2023
Tickers
BETRF
CYBN
DMTTF
DSNKY
Tags
MSSTF
News
Management
From
Benzinga
Small Pharma Implements Cost-Cutting Strategy To Reduce Cash Burn As Trial Progresses
June 29, 2023
Tickers
DMTTF
Tags
Market News
Guidance
Psychedelics Financing
From
Benzinga
Reunion Neuroscience's Q4 And Full Year 2023 Financial Results, To Close Take-Private Deal In Q3
June 29, 2023
Tickers
MSSTF
REUN
Tags
Guidance
Markets
Management
From
Benzinga
$100M Investment & Donation To Psychedelics Research From Toms Shoes Founder Blake Mycoskie
June 27, 2023
Tags
Blake Mycoskie
News
Psychedelics
From
Benzinga
Awakn Life Sciences Announces Closing Of Second Tranche And Upsizing Of Previous Private Placement
June 15, 2023
Tickers
AWKNF
Tags
Benzinga
Global
Psychedelic/Assisted Therapies
From
Benzinga
Canadian Financing: PharmAla Biotech Offers Non-Brokered Private Placement Up To $3.76M
June 13, 2023
Tickers
PMBHF
Tags
Markets
Guidance
News
From
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.